Author:
Azzari Chiara,Moriondo Maria,Di Pietro Pasquale,Di Bari Cesare,Resti Massimo,Mannelli Francesco,Esposito Susanna,Castelli-Gattinara Guido,Campa Antonio,de Benedictis Fernando Maria,Bona Gianni,Comarella Lisa,Holl Katsiaryna,Marchetti Federico
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. D’Ancona F, Alfonsi V, Caporali M, Ranghiasci A, Atti C d, on behalf of the Regional referents for infectious diseases and vaccinations. Pneumococcal conjugate, meningococcal C and varicella vaccination in Italy. Eurosurveillance. 2007;12:2.
2. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737–46.
3. Ansaldi F, de Florentis D, Canepa P, Bandettini R, Diana MC, Martini M, et al. Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccines. Hum Vaccin. 2011;7(Suppl):211–6.
4. Rodenburg GD, de Greeff SC, Jansen AG, de Melker HE, Schouls LM, Hak E, et al. Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands. Emerg Infect Dis. 2010;16:816–23.
5. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006;354:1455–63.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献